Abstract
Aluminum (Al) is found in parenteral nutrition (PN) solutions, accumulating in bone and liver of patients receiving PN therapy. Al is associated with low-turnover osteomalacia PN patients may also develop cholestasis (CS). We studied whether Al could intravenously(IV) 5 mg/kg/d for 14d (Group 1) (n=7) and 7d (Group II) (n=8) and 1 mg/kg/d for 14d (Group III) (n=6). Each group was pair-fed with littermate controls(C) given saline IV. Serum(S) total bile acids(BA), bile flow(BF), and A1 in bile(B) and urine(U) were determined. Results:
Biliary BA excretion did not differ among the groups.
Rats in Group I had higher SBA vs Group II (p<.05) but no different from Group III. BF in Group I was lower than in Group II (p<.03) and Group III (p<.05). In all groups BA1 excretion was only 3-7% of UA1 excretion. Thus, A1 can produce CS in rats in both a dose and time-related manner and must be considered in the etiology of TPN-associated cholestasis.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Klein, G., Heyman, M., Lee, T. et al. CHOLESTATIC EFFECTS OF ALUMINUM IN RATS. Pediatr Res 21 (Suppl 4), 271 (1987). https://doi.org/10.1203/00006450-198704010-00622
Issue Date:
DOI: https://doi.org/10.1203/00006450-198704010-00622